Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer.
Anker J, Pal SK, Kim-Schulze S, Wang H, Halperin R, Uzilov A, Imai N, Eikawa S, Saito T, Sebra R, Hahn NM, Patel M, Qi J, Xie H, Bhardwaj N, Gnjatic S, Galsky MD.
Anker J, et al. Among authors: galsky md.
J Immunother Cancer. 2023 Aug;11(8):e007613. doi: 10.1136/jitc-2023-007613.
J Immunother Cancer. 2023.
PMID: 37607770
Free PMC article.